Ezplaz Freeze Dried Plasma Fda Approved Tender in USA - 148088286

Procurement Summary

Country: USA

Summary: Ezplaz Freeze Dried Plasma Fda Approved

Deadline: 01 Sep 2026

Posting Date: 28 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 148088286

Document Ref. No.: HT942726QE015

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

This Sources Sought Notice (SSN) is for market research, information, and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the Defense Health Agency Contracting Activity (DHACA) or the DHA Portfolio Acquisition Executive Medical Products (PAE MP).
This SSN is being issued by DHACA on behalf of DHA PAE MP and is seeking sources to procure a Food and Drug Administration (FDA) approved Freeze Dried Plasma (FDP) product.
If capable sources are not identified through this notice, then DHACA intends to execute a firm-fixed price Indefinite Delivery/Indefinite Quantity contract on a sole source basis under the authority of the Revolutionary Federal Acquisition Regulation (FAR) Overhaul, FAR 6.103-1 to Vascular Solutions LLC, 6464 Sycamore Ct N, Maple Grove, Minnesota 55369-6032.
The DHA PAE MP has a requirement for supply of an FDA approved FDP product for transfusion when plasma is required and other plasma products are not available. The FDA approved Vascular Solutions, LLC FDP product, EZPLAZ™, on 29 July 2026. Vascular Solutions LLC holds the first and only FDA-approved (licensed) FPD product on the market.
This SSN is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed five (8.5 x 11 inch) pages using a font size no smaller than 10-point. The Government will consider all capability statements received by the due date of this notice. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to ...
Notice ID: ht942726qe015

Department/Ind. Agency: dept of defense

Sub-tier: defense health agency (dha)

Office: defense health agency

Product Service Code: 6505 - drugs and biologicals

NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Inactive Dates: sep 16, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice